Navigation Links
Bionovo to Present at the BMO Capital Markets Ninth Annual Focus on Healthcare Conference
Date:7/29/2009

EMERYVILLE, Calif., July 29 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI), a drug discovery and development company focused on the unmet needs in women's health and oncology, today announced that Dr. Mary Tagliaferri, President and Chief Medical Officer, and Tom Chesterman, Senior Vice President and CFO, will be presenting at the BMO Capital Markets Ninth Annual Focus on Healthcare Conference at 1:45 p.m. EDT on Wednesday, August 5, 2009. The event will be held at the Millennium Broadway Hotel in New York City.

Interested parties can access a live webcast of the presentation by visiting http://www.bmocm.com/conferences/2009healthcare/webcast/. A replay will be available for 6 months following the conference.

About Bionovo, Inc.

Bionovo, Inc. is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit: http://www.biono
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Bionovo Announces Closing of Public Offering of Common Stock
2. Bionovo Describes a New Class of Therapeutic Compounds
3. Bionovo Announces 2007 Financial Results and Highlights
4. Bionovo to Present at the Cambria Capital Investor Meeting
5. John D. Baxter, M.D. Joins Bionovos Board of Directors
6. Bionovo to Present at the Rodman & Renshaw 10th Annual Global Investment Conference
7. Bionovo to Present Recent Findings of BN108, its Anticancer Agent, at the 31st Annual San Antonio Breast Cancer Symposium
8. Willa A. Hsueh, M.D., Joins Bionovos Scientific Advisory Board
9. Bionovo Announces Cost Control Measures Taken
10. Bionovo Announces Presentation at the National Cancer Institute
11. Jan Ake Gustafsson, M.D., Ph.D., Joins Bionovos Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2014)... have characterized a set of clock genes that drive ... of species, from flies to humans. Over 15 mammalian ... are more. A team from the Perelman School of ... approaches could find them. , To accelerate clock-gene ... of Pharmacology and first author Ron Anafi, MD, PhD, ...
(Date:4/22/2014)... April 22, 2014 Researchers at UT Southwestern Medical ... from depression . , A team of ... by which ghrelin (a hormone with natural anti-depressant properties) ... potentially powerful new treatment for depression in the form ... The study, published online in April,s issue of ...
(Date:4/22/2014)... Calif.) The risk of pregnancy among women using ... is more than 10 times greater over a 10-year ... a study by researchers at Yale University and UC ... the medical journal Contraception , the study found ... method marketed under the brand name Essure. , ...
(Date:4/22/2014)... Washington, DC (April 22, 2014) The International ... May 22-26 in Seattle, Washington. The theme of ... life" means in a networked and digital society. ... and attended by over 2,200 Communication scholars representing ... largest scholarly international communication conference in the world. ...
(Date:4/22/2014)... is the standard measurement for assessing glycemic control over ... are typically measured every few months in a laboratory, ... accurately estimates A1c using self-monitored blood glucose (SMBG) readings, ... ( DTT ), a peer-reviewed journal from Mary Ann ... the DTT website at http://www.liebertpub.com/dtt . ...
Breaking Medicine News(10 mins):Health News:Bioinformatics profiling identifies a new mammalian clock gene 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 3Health News:Risk of pregnancy greater with newer method of female sterilization 2Health News:Risk of pregnancy greater with newer method of female sterilization 3Health News:International Communication Association to hold Annual Conference in Seattle, Washington 2
... suggests , , FRIDAY, Nov. 21 (HealthDay News) -- The season ... asthma, new research suggests. , Babies born in autumn -- about ... almost a 30 percent increased risk of asthma compared to babies ... the first December issue of the American Journal of Respiratory ...
... not given adequate drug therapy. This is the result of ... rzteblatt International ( Dtsch Arztebl Int 2008; 105[45]: ... this prospective, one-year survey. , 512 doctors in Germany took ... of whom 89.2% suffered from one or more cardiovascular diseases ...
... HUN ) today announced that its Founder and Chairman, ... American Cancer Society to,receive this year,s Medal of Honor, its ... who have made outstanding contributions to the,fight against cancer. , ... and his wife Karen Huntsman have "raised or,personally contributed over ...
... Nov. 21 Massachusetts Mutual Life,Insurance Company (MassMutual) ... Officers. , ... Vice President,and Chief Investment Officer, will assume the ... who remains Chairman and Chief Executive,Officer. Additionally, Mr. ...
... STOUGHTON, Mass., Nov. 21 Cardiosolutions, Inc.,( http://www.cardiosolutionsinc.com ... M.D., Ph.D. to the position of Chief Surgical ... Center for Aortic Surgery and Director of the,Marfan ... Department of,Thoracic and Cardiovascular Surgery at Cleveland Clinic. ...
... located in,Pittsburgh PA, and a subsidiary of Draeger, ... it believes are unsubstantiated allegations from,Sperian Respiratory Protection ... the popular Draeger PSS7000 SCBA (Self-Contained Breathing,Apparatus) used ... Draeger has a strong respect for intellectual ...
Cached Medicine News:Health News:Autumn Babies More Prone to Asthma 2Health News:Autumn Babies More Prone to Asthma 3Health News:Jon M. Huntsman Receives American Cancer Society Medal of Honor 2Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 2Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 3Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 4Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 5Health News:Cardiosolutions Names Dr. Lars Svensson Chief Surgical Officer 2Health News:Draeger Counters What It Believes Are Unsubstantiated Allegations of Patent Infringement by Sperian 2
(Date:1/15/2014)... 2014  Novation, the leading health care supply chain expertise, ... reseller (VAR) national contracts that expand its portfolio to ... lower costs. These include manufacturer product and service agreements, ... and ongoing IT consulting support. New ...
(Date:1/15/2014)... Jan. 15, 2014 Massachusetts General Hospital (MGH), ... AMGN ) announced today that they have launched ... new therapeutic targets and develop novel therapies for ... affects millions worldwide. The MGH-Broad-Amgen collaboration brings together ...
(Date:1/15/2014)... Jan. 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, ... the Journal of Drugs in Dermatology (JDD) ... (ODAC). The event is January 17-20, 2014, at the Omni Orlando ... The ODAC is a distinguished event ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
...  Volcano Corporation (NASDAQ: VOLC ), a leading ... guidance tools designed to enhance the treatment of coronary ... be participating in the 30th Annual J.P. Morgan Healthcare ... by Scott Huennekens, president and chief executive officer, will ...
... (NASDAQ: OPTR ) today announced that the Company ... on Tuesday, January 10 at 8:30 AM Pacific Time. ... live audio webcast of the presentation will be accessible on ... .   Replays of the presentation will be available at ...
Cached Medicine Technology:
Phacoemulsification system is a complete anterior segment surgical instrument. Its simplified design and unique innovations provide optimal surgical performance....
A gentle yet highly effective corneal rust ring remover with Alger brush of 1mm burr. Runs off 1 x AA battery, no switches, simply spin mandrel to operate....
Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings....
Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings. Ophtho-burr handpiece only. Battery powered handpiece....
Medicine Products: